Galectin Therapeutics Inc (GALT) Stock Price, Quote, News & History

GALTNASDAQ
$2.33
-0.04-1.69%
At close: Apr 24, 5:00 PM EST
$2.33
N/A
After Hours: 4:00 PM EST
Loading...

Key Statistics

Open
$2.36
Close
$2.33
Volume / Avg.
180.52K / 320.33K
Day Range
$2.32 - $2.39
52 Wk Range
1.21 - 7.13
Market Cap
$153.38M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
43
Short Interest
15.91%
Days to Cover
18.64

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-23.88M
Investing Cash Flow (TTM)
0
Financing Cash Flow (TTM)
26.48M
Free Cash Flow (TTM)
-23.88M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
2.60M

Analyst Trends and Forecast

1
Dec 25
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$270.97M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-20.34%
Earnings Yield % (FWD)
-13.14%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$1.95

Company Debt

Total Debt
$133.74M
LT Debt
$133.74M
LT Debt Issuance (TTM)
$21.00M
LT Debt Repayment (TTM)
-
Total Cash
$17.72M
Debt to Equity
-
Issuance of Debt (TTM)
$21.00M
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.36
Close
$2.33
Volume / Avg.
180.52K / 320.33K
Day Range
$2.32 - $2.39
52 Wk Range
1.21 - 7.13
Market Cap
$153.38M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
43
Short Interest
15.91%
Days to Cover
18.64

About

Sector
Health Care
Industry
Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (G...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Galectin Therapeutics (GALT) stock?

A

You can purchase shares of Galectin Therapeutics (NASDAQ:GALT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Galectin Therapeutics (GALT) competitors?

A

There are no as such competitors for Galectin Therapeutics.

Q

What is the forecast, or price target, for Galectin Therapeutics (GALT) stock?

A

Galectin Therapeutics has a consensus price target of $8.50.

Q

What is the current price for Galectin Therapeutics (GALT)?

A

The stock price for Galectin Therapeutics (NASDAQ: GALT) is $2.33 last updated April 24, 2026 at 4:00 PM EDT.

Q

Does Galectin Therapeutics (GALT) pay a dividend?

A

There are no upcoming dividends for Galectin Therapeutics.

Q

When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?

A

Galectin Therapeutics does not have any upcoming earnings scheduled.

Q

Is Galectin Therapeutics (GALT) going to split?

A

There is no upcoming split for Galectin Therapeutics.

Q

What sector and industry does Galectin Therapeutics (GALT) operate in?

A

Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.